Skip to Content

Trained immunity in viral infections, Alzheimer’s disease and multiple sclerosis

Type I interferon presents in such as Alzheimer’s disease (AD) and multiple sclerosis (MS), where viral infections are known to increase symptomatic burden – and a the same time, we know, that Type I interferon (IFN-I) signalling represents a major target for modulation in a virus’ bid for latency.

George D. Vavougios

Få adgang til artiklen

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top